1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia Pacific

This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

The pharma growth pattern in the developed market is continuing to flatten; globally, generic war is heating up and pharma companies are bleeding to sustain their business. With every passing year, more and more bio-molecules are losing exclusivity and are subjected to generic competition. At the same time, improving global hygiene and better prognostic facilities are further adding to the misery of the pharma industry.

Industry players are forced to look out for an alternate and sustainable source of revenue, as well as maintain their profitability. In this darkening global pharma outlook, Asia Pacific’s strong economic fundamentals have given a ray of hope to players across the globe. The Asia Pacific region has emerged as a leader in pharmaceutical R&D, aided by the availability of a large patient population, lower costs and skilled manpower. Several emerging trends such as improved government spending on healthcare, customer health cognizance, increasing middle-class income and ever-growing incidence of chronic disease have increased demand for pharmaceutical products in the region. As per the Economist Intelligence Unit (EIU) estimate, the region’s pharmaceutical sales are expected to hit US$386 billion in 2016 with a strong compounded annual growth rate of more than 13%.

It is believed that the Asia Pacific region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials. Asia Pacific is the fastest growing pharma market and is going through tremendous change due to international and local developments.

Table Of Contents

Emerging Pharma Trends that will Revolutionize the Healthcare Landscape in the Asia Pacific

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.